KRISTINA ATKINSON: Open Payments
NPI 1265703524 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 15 payments from 9 companies in 2025. Trend: 2023 $1,387 · 2024 $958 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 5 | $177 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Genentech, Inc. | 1 | $34 |
| Eisai Inc. | 1 | $31 |
| ABBVIE INC. | 2 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Genmab U.S., Inc. | 1 | $21 |
| Legend Biotech USA Inc. | 1 | $14 |
Products named: DATROWAY, Enhertu, KEYTRUDA, Itovebi, Lenvima, ELAHERE, Orserdu, Tivdak.
Industry payments across OK — which companies pay providers there.
